Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

VEGF-C expression in oral cancer by neurotransmitter-induced activation of beta-adrenergic receptors (2013)

  • Authors:
  • USP affiliated authors: OLIVEIRA, DENISE TOSTES - FOB
  • USP Schools: FOB
  • DOI: 10.1007/s13277-012-0521-1
  • Subjects: NEOPLASIAS; BOCA; RECEPTORES ADRENÉRGICOS
  • Language: Inglês
  • Imprenta:
  • Source:
    • Título do periódico: Tumor Biology
    • ISSN: 1010-4283
    • Volume/Número/Paginação/Ano: v. 34, n. 1, p. 139-143, Feb. 2013
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s13277-012-0521-1 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Versões disponíveis em Acesso Aberto do: 10.1007/s13277-012-0521-1 (Fonte: Unpaywall API)

    Título do periódico: Tumor Biology

    ISSN: 1010-4283,1423-0380



      Não possui versão em Acesso aberto
    Informações sobre o Citescore
  • Título: Tumor Biology

    ISSN: 1010-4283

    Citescore - 2017: 3.27

    SJR - 2017: 1.149

    SNIP - 2017: 0.825


  • How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      VILARDI, Bruna Maria Rodrigues; BRAVO-CALDERÓN, Diego Mauricio; BERNABÉ, Daniel Galera; OLIVEIRA, Sandra Helena Penha; OLIVEIRA, Denise Tostes. VEGF-C expression in oral cancer by neurotransmitter-induced activation of beta-adrenergic receptors. Tumor Biology, Basel, v. 34, n. 1, p. 139-143, 2013. Disponível em: < http://dx.doi.org/10.1007/s13277-012-0521-1 > DOI: 10.1007/s13277-012-0521-1.
    • APA

      Vilardi, B. M. R., Bravo-Calderón, D. M., Bernabé, D. G., Oliveira, S. H. P., & Oliveira, D. T. (2013). VEGF-C expression in oral cancer by neurotransmitter-induced activation of beta-adrenergic receptors. Tumor Biology, 34( 1), 139-143. doi:10.1007/s13277-012-0521-1
    • NLM

      Vilardi BMR, Bravo-Calderón DM, Bernabé DG, Oliveira SHP, Oliveira DT. VEGF-C expression in oral cancer by neurotransmitter-induced activation of beta-adrenergic receptors [Internet]. Tumor Biology. 2013 ; 34( 1): 139-143.Available from: http://dx.doi.org/10.1007/s13277-012-0521-1
    • Vancouver

      Vilardi BMR, Bravo-Calderón DM, Bernabé DG, Oliveira SHP, Oliveira DT. VEGF-C expression in oral cancer by neurotransmitter-induced activation of beta-adrenergic receptors [Internet]. Tumor Biology. 2013 ; 34( 1): 139-143.Available from: http://dx.doi.org/10.1007/s13277-012-0521-1

    Referências citadas na obra
    Schuller HM. Neurotransmission and cancer: implications for prevention and therapy. Anticancer Drugs. 2008;19(7):655–71. doi: 10.1097/CAD.0b013e3283025b5800001813-200808000-00001 .
    Armaiz-Pena GN, Lutgendorf SK, Cole SW, Sood AK. Neuroendocrine modulation of cancer progression. Brain Behav Immun. 2009;23(1):10–5.
    Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA. 1992;267(9):1244–52.
    Hasegawa H, Saiki I. Psychosocial stress augments tumor development through beta-adrenergic activation in mice. Jpn J Cancer Res. 2002;93(7):729–35.
    Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol. 2004;5(10):617–25.
    Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol. 2009;5(7):374–81.
    Sherman DK, Bunyan DP, Creswell JD, Jaremka LM. Psychological vulnerability and stress: the effects of self-affirmation on sympathetic nervous system responses to naturalistic stressors. Health Psychol. 2009;28(5):554–62.
    Yang EV, Sood AK, Chen M, Li Y, Eubank TD, Marsh CB, et al. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res. 2006;66(21):10357–64.
    Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med. 2006;12(8):939–44.
    Yang EV, Donovan EL, Benson DM, Glaser R. VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine. Brain Behav Immun. 2008;22(3):318–23.
    Yang EV, Kim SJ, Donovan EL, Chen M, Gross AC, Webster Marketon JI, et al. Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immun. 2009;23(2):267–75.
    Guo K, Ma Q, Wang L, Hu H, Li J, Zhang D, et al. Norepinephrine-induced invasion by pancreatic cancer cells is inhibited by propranolol. Oncol Rep. 2009;22(4):825–30.
    Tilan J, Kitlinska J. Sympathetic neurotransmitters and tumor angiogenesis-link between stress and cancer progression. J Oncol. 2010;2010:539706. doi: 10.1155/2010/539706 .
    Madden KS, Szpunar MJ, Brown EB. Beta-adrenergic receptors (beta-AR) regulate VEGF and IL-6 production by divergent pathways in high beta-AR-expressing breast cancer cell lines. Breast Cancer Res Treat. 2011;130(3):747–58. doi: 10.1007/s10549-011-1348-y .
    Park SY, Kang JH, Jeong KJ, Lee J, Han JW, Choi WS, et al. Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1α protein-dependent mechanism. Int J Cancer. 2011;128(10):2306–16. doi: 10.1002/ijc.25589 .
    Schuller HM. Neurotransmitter receptor-mediated signaling pathways as modulators of carcinogenesis. Prog Exp Tumor Res. 2007;39:45–63. doi: 100045 .
    Fitzgerald PJ. Is norepinephrine an etiological factor in some types of cancer? Int J Cancer. 2009;124(2):257–63. doi: 10.1002/ijc.24063 .
    Shang ZJ, Liu K, de Liang F. Expression of beta2-adrenergic receptor in oral squamous cell carcinoma. J Oral Pathol Med. 2009;38(4):371–6. doi: JOP691 .
    Bernabé DG, Tamae AC, Biasoli ER, Oliveira SH. Stress hormones increase cell proliferation and regulates interleukin-6 secretion in human oral squamous cell carcinoma cells. Brain Behav Immun. 2011;25(3):574–83.
    Bravo-Calderón DM, Oliveira DT, Marana AN, Nonogaki S, Carvalho AL, Kowalski LP. Prognostic significance of beta-2 adrenergic receptor in oral squamous cell carcinoma. Cancer Biomark. 2011–2012;10(1):51–9.
    Lohela M, Bry M, Tammela T, Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol. 2009;21(2):154–65.
    Hirakawa S, Brown LF, Kodama S, Paavonen K, Alitalo K, Detmar M. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood. 2007;109(3):1010–7.
    Siriwardena BS, Kudo Y, Ogawa I, Udagama MN, Tilakaratne WM, Takata T. VEGF-C is associated with lymphatic status and invasion in oral cancer. J Clin Pathol. 2008;61(1):103–8.
    Matsuura M, Onimaru M, Yonemitsu Y, Suzuki H, Nakano T, Ishibashi H, et al. Autocrine loop between vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 positively regulates tumor-associated lymphangiogenesis in oral squamoid cancer cells. Am J Pathol. 2009;175(4):1709–21.
    Sugiura T, Inoue Y, Matsuki R, Ishii K, Takahashi M, Abe M, et al. VEGF-C and VEGF-D expression is correlated with lymphatic vessel density and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker. Int J Oncol. 2009;34(3):673–80.
    Bock JM, Sinclair LL, Bedford NS, Jackson RE, Lee JH, Trask DK. Modulation of cellular invasion by VEGF-C expression in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2008;134(4):355–62.
    Lutgendorf SK, Cole S, Costanzo E, Bradley S, Coffin J, Jabbari S, et al. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin Cancer Res. 2003;9(12):4514–21.
    Warburton G, Nikitakis NG, Roberson P, Marinos NJ, Wu T, Sauk Jr JJ, et al. Histopathological and lymphangiogenic parameters in relation to lymph node metastasis in early stage oral squamous cell carcinoma. J Oral Maxillofac Surg. 2007;65(3):475–84.
    Chen G, Liu XY, Wang Z, Liu FY. Vascular endothelial growth factor C: the predicator of early recurrence in patients with N2 non-small-cell lung cancer. Eur J Cardiothorac Surg. 2010;37(3):546–51.
    Thaker PH, Lutgendorf SK, Sood AK. The neuroendocrine impact of chronic stress on cancer. Cell Cycle. 2007;6(4):430–3. doi: 3829 .